Platinum(IV) Metallacrown Ethers: Synthesis, Structures, Host Properties and Anticancer Evaluation

Abstract

Platinum(IV) metallacrown ethers [PtBr2Me2{im(CH2CH2O)xCH2CH2im}] (im = imidazol-1-yl; x = 2−5, 7; 3−7) and [PtBr2Me2{bim(CH2CH2O)xCH2CH2bim}] (bim = benzimidazol-1-yl; x = 1, 2, 5, 7; 9−12) were synthesized via the reaction of [(PtBr2Me2)n] with the appropriate α,ω-bis(imidazol-1-yl) or α,ω-bis(benzimidazol-1-yl) polyether. Reactions with 1,2-bis(imidazol-1-yl)ethane, bis(2-(imidazol-1-yl)ethyl) ether, or 1,2-bis(benzimidazol-1-yl)ethane yielded the dinuclear complexes [(PtBr2Me2)2{μ-im(CH2CH2O)xCH2CH2im}2] (x = 0, 1; 1, 2) and [(PtBr2Me2)2{μ-bimCH2CH2bim}2] (8), respectively. In addition, the diiodo complex [PtI2Me2{im(CH2CH2O)2CH2CH2im}] (13) was prepared from the reaction of [PtMe2(cod)] with I2 in the presence of im(CH2CH2O)2CH2CH2im. Characterization by microanalysis and NMR spectroscopy, as well as X-ray crystal structure analysis of several of the metallacrown ethers (3, 5, 9 and 10) and dinuclear complexes (2 and 8), is described. The ability of the larger metallacrown ethers (5−7, 11 and 12) to ...